Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Navin Fluorine International Ltd (NFIL)., part of the Padmanabh Mafatlal Group, announced the new identity for its contract development and manufacturing division, Navin Molecular.
read more
Sunday, September 18, 2016
Navidea Biopharmaceuticals has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has granted a positive opinion for a new Lymphoseek® 50 microgram kit for radiopharmaceutical preparation.
read more
Tuesday, December 08, 2020
Natoli Engineering has hired Gerardo Zuniga as their new West Coast Service Technician based at their Southern California Technical Center.
read more
Wednesday, December 23, 2020
Natoli Engineering has hired Danny Yadram Chandarballi as the Northeast Service Technician based at the Long Island Technical Center.
read more
Forty-five percent of Americans who use opioid prescription painkillers do not realize they are taking an opioid, or that the drug is just as addictive as heroin, according to a National Safety Council survey
read more
Tuesday, February 20, 2024
National Resilience, Inc. (Resilience) announced the expansion of the company’s clinical and commercial drug product manufacturing capabilities across its network. By scaling this capacity, Resilience aims to provide over 200 million units to its ...
read more
Thursday, August 16, 2018
Natera has partnered with Fox Chase Cancer Center to assess the company's Signatera customized circulating tumor DNA (ctDNA) assay for recurrence monitoring of kidney cancer.
read more
Friday, September 14, 2018
Natera announced an agreement with Bristol-Myers Squibb to use Natera's Signatera custom circulating tumor DNA assay in a Phase 2 study in the adjuvant non-small cell lung cancer setting.
read more
Thursday, February 03, 2022
Nashville Biosciences and Datavant announced a collaboration that will enable biopharma companies to connect their trial data to research datasets from BioVU®. The linkages will accelerate drug discovery, clinical development, and drug safety ...
read more
Monday, September 25, 2017
Jaguar Health announced its wholly-owned subsidiary, Napo Pharmaceuticals, has entered into a Termination, Asset Transfer and Transition Agreement with India-based Glenmark Pharmaceuticals.
read more
Tuesday, September 14, 2021
Naobios, a CDMO providing bioprocess development and GMP production of clinical batches of viral vaccines BSL2/BSL3, oncolytic viruses and viral vectors, announces the next phase in its partnership with FluGen, Inc., a clinical-stage vaccine company ...
read more
Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of clinical batches of virus-based products, announced the signing of a partnership with Sumagen, a Korean-Canadian ...
read more
Naobios and SGS announce their partnership in the manufacturing of a Respiratory Syncytial Virus (RSV) challenge agent for use in Controlled Human Infection Model (CHIM) studies conducted by SGS.
read more
Nanotherapeutics has received two new Task Orders from The United States Department of Health and Human Services, Biomedical Advanced Research and Development Authority Fill-Finish Manufacturing Network’s Pilot Production program, for the Center for...
read more
Friday, December 02, 2016
Nanotherapeutics, Inc., a contract development and manufacturing organization (CDMO), announced that Prasad Raje, Ph.D., has been appointed President and Chief Executive Officer, succeeding James M. Matthew, who served as interim President and Chief ...
read more